Childhood Vaccine Schedules Across Countries

Childhood vaccination policies vary significantly around the world, with American children receiving up to 75 vaccines—much more than children in other countries. This content discusses the need for a comprehensive study on vaccine safety and the efficacy of the current vaccine schedule in the U.S., particularly in light of President Trump's executive orders aimed at reforming vaccination practices.

1. Executive Orders by President Trump:

Executive Order 14407 (issued May 29, 2026) mandates that U.S. vaccine recommendations align with international best practices, requiring assessment of safety and vaccine monitoring.

Executive Order 14420 (issued August 10, 2026) aims to reduce immunization recommendations and suggests separating the combined MMR vaccine into three doses.

2. Task Force Inaction:

Despite the directives, there has been little progress. The Task Force on Safer Childhood Vaccines, led by NIH Director Jay Bhattacharya, has not made any appointments or shared plans for the study.

There is no proposed study design or comment solicitation from the public, leading to concerns that the executive orders are being ignored.

3. International Vaccine Schedules:

Different countries have varying numbers of recommended or mandated vaccines:

U.S.: 30 to 75 doses by age 18.

Denmark: 30-38 recommended.

Bulgaria: 56-61 recommended.

Other countries, such as Norway and Sweden, have no mandatory vaccines.

The variations raise questions about the effectiveness and safety of different immunization strategies.

4. Research Gaps:

The U.S. has lagged in studying the cumulative effects of vaccines. Previous assessments have called for better monitoring and evaluation of vaccine safety.

The Institute of Medicine reported in 2013 that long-term effects of vaccines had not been studied properly, recommending more robust surveillance.

5. Need for Scientific Studies:

There is an urgent need for scientifically rigorous studies comparing U.S. vaccine schedules with those in peer countries, focusing on health outcomes and safety.

Experts should be involved in designing these studies, ensuring transparency and accountability in the process.

6. Recommendations for Action:

Create a study protocol that includes comparisons of different vaccination strategies.

Involve a multi-disciplinary team to design the study and establish clear safety and efficacy endpoints.

Convert passive event reporting into active monitoring of vaccine safety.

Ensure transparency regarding vaccine ingredients and findings, and hold public discussions about results.

The discussion highlights the pressing need for a thorough evaluation of the U.S. childhood vaccination schedule in comparison to other countries. Despite executive mandates for reform, significant inaction and procrastination exist. There is a clear call for the involved agencies to fulfill their responsibilities, ensuring that Americans receive well-researched and transparent information regarding vaccine safety and efficacy. This is seen as a critical opportunity to improve public health policies and build trust in the vaccination process. 

https://brownstone.org/articles/childhood-vaccine-schedules-across-countries/